Gsa Capital Partners LLP Mannkind Corp Transaction History

Gsa Capital Partners LLP

$1.43 Billion
Q2 2025

A detailed history of Gsa Capital Partners LLP transactions in Mannkind Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 233,558 shares of MNKD stock, worth $854,822. This represents 0.06% of its overall portfolio holdings.

Number of Shares

233,558

Previous 44,206 428.34%

Holding current value

$854,822

Previous $222,000 293.69%

% of portfolio

0.06%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	BUY	$3.71 - $5.04 $702,495 - $954,334	189,352 Added 428.34%	233,558 $874,000
Q1 2025 May 08, 2025	SELL	$4.92 - $6.6 $1.28 Million - $1.72 Million	-260,375 Reduced 85.49%	44,206 $222,000
Q4 2024 Feb 07, 2025	BUY	$5.93 - $7.44 $1.72 Million - $2.15 Million	289,239 Added 1885.28%	304,581 $1.96 Million
Q3 2024 Nov 05, 2024	SELL	$5.01 - $6.7 $2.28 Million - $3.05 Million	-455,700 Reduced 96.74%	15,342 $97,000
Q2 2024 Aug 15, 2024	SELL	$4.05 - $5.43 $625,190 - $838,218	-154,368 Reduced 24.68%	471,042 $2.46 Million
Q1 2024 May 03, 2024	BUY	$3.25 - $5.27 $405,886 - $658,159	124,888 Added 24.95%	625,410 $2.83 Million
Q4 2023 Feb 16, 2024	BUY	$3.34 - $4.29 $1.13 Million - $1.45 Million	337,494 Added 207.02%	500,522 $1.82 Million
Q3 2023 Nov 15, 2023	BUY	$3.91 - $5.45 $637,439 - $888,502	163,028 New	163,028 $673,000
Q1 2023 May 12, 2023	BUY	$3.95 - $5.63 $347,339 - $495,068	87,934 Added 205.18%	130,790 $536,000
Q4 2022 Feb 13, 2023	BUY	$3.02 - $5.37 $129,425 - $230,136	42,856 New	42,856 $226,000
Q2 2022 Aug 09, 2022	BUY	$2.67 - $4.77 $32,897 - $58,771	12,321 New	12,321 $47,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $40,998 - $54,360	-10,123 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.89 - $5.48 $817,261 - $1.15 Million	-210,093 Reduced 95.4%	10,123 $44,000
Q2 2021 Aug 05, 2021	BUY	$3.61 - $5.45 $456,076 - $688,536	126,337 Added 134.57%	220,216 $1.2 Million
Q1 2021 May 10, 2021	BUY	$3.14 - $6.14 $243,393 - $475,935	77,514 Added 473.66%	93,879 $368,000
Q4 2020 Feb 03, 2021	SELL	$1.79 - $4.04 $160,654 - $362,594	-89,751 Reduced 84.58%	16,365 $51,000
Q3 2020 Nov 06, 2020	BUY	$1.56 - $2.08 $165,540 - $220,721	106,116 New	106,116 $199,000
Q3 2018 Nov 13, 2018	SELL	$1.01 - $2.19 $115,160 - $249,703	-114,020 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$1.59 - $2.38 $181,291 - $271,367	114,020 New	114,020 $217,000

Others Institutions Holding MNKD

# of Institutions

248

Shares Held

161M

Call Options Held

1.24M

Put Options Held

183K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $942M
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Mannkind Corp Transaction History